3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Insulin Resistance
1
Hyperandrogenism
1
Glucose Intolerance
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Anovulation
1
Interventions
Metformin
21
Inositol
14
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sex Characteristics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Inulin
×
1 year
×
Clear all
NCT03864068
2026-01-07
INSUPP-PCOS
Milton S. Hershey Medical Center
Phase 2
Completed
154 enrolled